Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jonas B. Vischedyk"'
Autor:
Fatima Baker, Ibrahim H. Polat, Khalil Abou-El-Ardat, Islam Alshamleh, Marlyn Thoelken, Daniel Hymon, Andrea Gubas, Sebastian E. Koschade, Jonas B. Vischedyk, Manuel Kaulich, Harald Schwalbe, Shabnam Shaid, Christian H. Brandts
Publikováno v:
Cancers
Cancers, Vol 13, Iss 6142, p 6142 (2021)
Cancers, Vol 13, Iss 6142, p 6142 (2021)
Simple Summary The importance of autophagy in leukemia progression and survival has been studied previously. However, little is known about the development of resistance mechanisms to autophagy inhibition in leukemia. Here, we present data on the mec
Autor:
Rajkumar Savai, Jean Schneikert, Niklas Gremke, Thorsten Stiewe, Anne Catherine Bretz, Mirjam Hefter, Julia R Seiz, Jonas B. Vischedyk, Magdalena Noack, Miriam P. Gittler, Andrea Nist, Joël P. Charles, Marco Mernberger, Michael Wanzel
Publikováno v:
Nature chemical biology
Inactivation of the p53 tumor suppressor by Mdm2 is one of the most frequent events in cancer, so compounds targeting the p53-Mdm2 interaction are promising for cancer therapy. Mechanisms conferring resistance to p53-reactivating compounds are largel
Autor:
Maximilian Kleint, Fotini Vogiatzi, Michael Wanzel, Andrea Nist, Jeannette Fuchs, Joël P. Charles, Jonas A. Schäfer, Jonas B. Vischedyk, Oleg Timofeev, Thorsten Stiewe, Mirjam Hefter
Publikováno v:
Nature Communications
Tumours are heterogeneous cell populations that undergo clonal evolution during tumour progression, metastasis and response to therapy. Short hairpin RNAs (shRNAs) generate stable loss-of-function phenotypes and are versatile experimental tools to ex
Autor:
Thorsten Stiewe, Jean Schneikert, Andrea Nist, Jonas B. Vischedyk, Joël P. Charles, Michael Wanzel, Marco Mernberger, Niklas Gremke, Miriam P. Gittler, Anne Catherine Bretz
Publikováno v:
European Journal of Cancer. 61:S122